Lee Hambright's Stock Ratings

Bernstein Analyst

Lee Hambright is an analyst at Bernstein. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025

Overall Average Return

13.3%

Smart Score

69.7%

Overall Average Return Percentile

68th

Number of Ratings

22
Buy NowGet Alert
11/20/2024MDTBuy Now
Medtronic
$86.4412.22%
Lee Hambright69%
$96 → $97MaintainsOutperformGet Alert
11/06/2024PODDBuy Now
Insulet
$324.75-7.62%
Lee Hambright69%
→ $300Initiates → OutperformGet Alert
11/06/2024TNDMBuy Now
Tandem Diabetes Care
$23.0881.98%
Lee Hambright69%
→ $42Initiates → OutperformGet Alert
10/25/2024DXCMBuy Now
DexCom
$84.511.76%
Lee Hambright69%
$82 → $86MaintainsOutperformGet Alert
10/24/2024BSXBuy Now
Boston Scientific
$105.20-4.94%
Lee Hambright69%
$92 → $100MaintainsOutperformGet Alert
10/17/2024ABTBuy Now
Abbott Laboratories
$134.082.92%
Lee Hambright69%
$133 → $138MaintainsOutperformGet Alert
05/31/2023ISRGBuy Now
Intuitive Surgical
$564.00-35.28%
Lee Hambright69%
$350 → $365MaintainsOutperformGet Alert
05/26/2023MDTBuy Now
Medtronic
$86.4414.53%
Lee Hambright69%
$100 → $99MaintainsOutperformGet Alert
05/03/2023ZBHBuy Now
Zimmer Biomet Holdings
$96.7557.11%
Lee Hambright69%
$136 → $152MaintainsMarket PerformGet Alert
04/20/2023ISRGBuy Now
Intuitive Surgical
$564.00-37.94%
Lee Hambright69%
$325 → $350MaintainsOutperformGet Alert
01/26/2023ABTBuy Now
Abbott Laboratories
$134.08-1.55%
Lee Hambright69%
$125 → $132MaintainsOutperformGet Alert
07/15/2022DXCMBuy Now
DexCom
$84.5124.24%
Lee Hambright69%
→ $105Initiates → OutperformGet Alert
03/16/2022JNJBuy Now
Johnson & Johnson
$151.0021.19%
Lee Hambright69%
→ $183DowngradeOutperform → Market PerformGet Alert
03/16/2022SYKBuy Now
Stryker
$394.21-25.17%
Lee Hambright69%
$288 → $295UpgradeMarket Perform → OutperformGet Alert
03/16/2022EWBuy Now
Edwards Lifesciences
$78.0073.08%
Lee Hambright69%
$132 → $135UpgradeMarket Perform → OutperformGet Alert
10/11/2019JNJBuy Now
Johnson & Johnson
$151.00—
Lee Hambright69%
—UpgradeMarket Perform → OutperformGet Alert
06/27/2018SYKBuy Now
Stryker
$394.21-55.1%
Lee Hambright69%
→ $177Initiates → Market PerformGet Alert
06/27/2018JNJBuy Now
Johnson & Johnson
$151.00-14.57%
Lee Hambright69%
→ $129Initiates → Market PerformGet Alert
06/27/2018EWBuy Now
Edwards Lifesciences
$78.00111.54%
Lee Hambright69%
→ $165Initiates → Market PerformGet Alert
12/04/2014EWBuy Now
Edwards Lifesciences
$78.0098.72%
Lee Hambright69%
→ $155Initiates → OutperformGet Alert
10/01/2014JNJBuy Now
Johnson & Johnson
$151.00—
Lee Hambright69%
—Downgrade → Market PerformGet Alert
11/25/2013SYKBuy Now
Stryker
$394.21-78.69%
Lee Hambright69%
$75 → $84UpgradeMarket Perform → OutperformGet Alert